Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Retatrutide is a triple agonist of the GIP, GLP-1, and glucagon receptors that is currently in development
"I think that there are some companies that do a great job [with obesity treatment] and others where they are simply dispensing the medication, and there's no follow-up or there's no ability to monitor someone's conditions," she said
Until such trials are completed, the compound remains experimental
Always inform your provider of your complete medical history and all current medications before beginning treatment
Are compounded GLP-1 medications safe for long-term cholesterol management
Always check the storage guidelines and discard any vial that shows visible changes or has exceeded its storage timeline
US$ 20.06
US$ 24.75
US$ 26.24
US$ 29.32
US$ 25.70
US$ 23.03
US$ 21.46
US$ 22.00
US$ 23.33
US$ 28.27
